BEACON EMR HIPAA Disclaimer Site Map Social Media
BayCare Health System
Community Benefit Financial Assistance Policy Quality Report Card Health Library News Doctor Connect Find Us
Services Hospitals Find A Doctor Classes & Events About Us Careers Contact Us Get E-Newsletter
AML Panel by FISH
 Back  Back

May We Help You?

Call 1-877-692-2922
Monday-Friday, 8am to 5pm

Persons with hearing and speech disabilities can reach the above number through TDD and other specialized equipment by calling the Florida Relay Service at 711.

Contact Us
Search jobs

Decrease (-) Restore Default Increase (+) Font Size
Print    Email

AML Panel by FISH

Test name:
AML panel by FISH (inv16, t(15;17), t(8;21), MLL)

Order name:
AML panel by FISH request

Specimen requirements:
Sodium heparin peripheral blood or bone marrow

Minimum volume:
1 mL

Storage and stability information:
Room temperature 3 days

Test performed:
Twice per week

Fluorescence in situ hybridization

Reference range:
See lab report

Clinical significance:
The t(8;21) translocation is found in 7-8% of patients with cytogenetically abnormal acute myelogenous leukemia (AML) and in adults usually predicts good response to chemotherapy with a high remission rate and a relatively long median survival. Abnormalities of 11q23 are found in 2% of cytogenetically abnormal adult AML cases and 10% of pediatric AML cases and are generally associated with a poor prognosis.  The t(15;17) translocation has been described in almost 100% of Acute Promyelocytic Leukemia (APL) cases. This subtype of AML is sensitive to all-trans retinoic acid (ATRA) has the highest complete remission rate, and the longest median survivals for patients with AML.  Inversion of chromosome 16 is seen in 4% of cytogenetically abnormal AML cases and has a very high complete remission rate and long median survival.

CPT codes:
88368 x 8

Serving The Tampa Bay Area © Copyright 2014 BayCare Health System